Friday, July 10, 2026
🇺🇸 FDA

Drug profile · INN

human papillomavirus 9-valent vaccine (recombinant, adsorbed)

GARDASIL 9

human papillomavirus 9-valent vaccine (recombinant, adsorbed) (GARDASIL 9) is a biological vaccine - induces immune response.

EMA: approved Antiinfectives for systemic use (J07) J07BM03
Patents linked 14
Pipeline programs 9
News articles 0
Drug details — human papillomavirus 9-valent vaccine (recombinant, adsorbed)
Class
Antiinfectives for systemic use (J07)
Route
—
Patents
14
Programs
9
Data quality
0.83
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

human papillomavirus 9-valent vaccine (recombinant, adsorbed) (GARDASIL 9) is a biological vaccine - induces immune response.

Key facts

INN human papillomavirus 9-valent vaccine (recombinant, adsorbed)
Brand GARDASIL 9
Mechanism Biological vaccine - induces immune response
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07BM03

Mechanism of action

Biological vaccine - induces immune response

Approval history

Authority Status Date
EMA approved —

Pipeline programs

Search pipeline
  1. 2024/4031 Phase 3 · George Institute for · Patients with primary HPV high-grade squamous intra-epitheli
  2. APHP200046 Phase 3 · PARItec · HPV vaccine
  3. P150957 Phase 3 · PARItec · External Genital Warts (EGW)
  4. P170938J Phase 3 · PARItec · Asplenia
  5. V503-021 Phase 3 · MSD Merck Sharp · ​9vHPV vaccine is indicated in females ≥ 9 years of age in t
  6. ALLO-HPV Phase 2 · AstraZeneca · Recipients of allogeneic stem cell transplantation
  7. Gardasil 9 suspension for Evaluation of the reduction of… Approved · George Institute for · Evaluation of the reduction of HPV infectivity and transmiss
  8. Sodium Chloride 0.9% for Vulvar High-Grade Squamous Intr… Approved · Disc Medicine · Vulvar High-Grade Squamous Intraepithelial Lesion (vHSIL)

Related & competitor drugs

Browse all drugs
  1. atazanavir sulfate Antiinfectives for systemic use (J05)
  2. colistimethate sodium Antiinfectives for systemic use (J01)
  3. covid-19 mrna vaccine Antiinfectives for systemic use (J07)
  4. daptomycin Antiinfectives for systemic use (J01)
  5. darunavir Antiinfectives for systemic use (J05)
  6. dengue tetravalent vaccine (live, attenuated) Antiinfectives for systemic use (J07)

Related patents

Browse patents

  1. SI 2158199

    PIPERIDINE COMPOUNDS AND USES THEREOF

    Expires Sun Feb 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. EP 2079730

    MGLUR5-MODULATOREN

    Expires Tue Jul 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. EP 2064340

    VERFAHREN ZUR BEWERTUNG VON PATIENTEN BEI DER BEHANDLUNG MIT AUF RET-REZEPTOR-TYROSINKINASE ABZIELENDEN ARZNEISTOFFEN

    Expires Tue May 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. AR 065277

    COMBINACIONES DE BENZOTIAZOLONA AGONISTA 2-BETA-ADRENOCEPTOR

    Expires Tue May 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. AR 065278

    SALES DE DERIVADO DE BENZOTIAZOL

    Expires Tue May 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. AR 065042

    DERIVADOS DE CINNOLINA, PROCESOS DE OBTENCION Y COMPOSICIONES FARMACEUTICAS

    Expires Tue May 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. EP 2057147

    PYRIMIDIN-DERIVATE

    Expires Tue May 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. AR 064864

    COMPUESTOS ANALOGOS DE PIRIDINA VII 543 Y COMPOSICION FARMACEUTICA

    Expires Tue Apr 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. EP 2044063

    FÜR DIE BEHANDLUNG VON KREBS GEEIGNETE PYRIMIDINDERIVATE

    Expires Tue Apr 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. EP 2044050

    NEUE PYRIDINANALOGA

    Expires Tue Apr 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. AR 064495

    DERIVADOS DE PIPERIDIN-CARBONILFENIL SULFONAMIDAS

    Expires Tue Apr 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. EP 2041112

    NEUE PYRIDINANALOGA

    Expires Tue Mar 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. EP 2041135

    ALS MODULATOREN VON TLR7 WIRKENDE 8-OXOADENINDERIVATE

    Expires Tue Mar 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. EP 2035418

    NEUE HETEROARYLSUBSTITUIERTE BENZOXAZOLE

    Expires Tue Mar 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is human papillomavirus 9-valent vaccine (recombinant, adsorbed)?

human papillomavirus 9-valent vaccine (recombinant, adsorbed) (GARDASIL 9) is a biological vaccine - induces immune response.

What is the brand name for human papillomavirus 9-valent vaccine (recombinant, adsorbed)?

GARDASIL 9 is a marketed brand name for human papillomavirus 9-valent vaccine (recombinant, adsorbed). Check FDA Drugs@FDA for the current US label holder and prescribing information.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.